Asanidze Elene, Kristesashvili Jenaro, Parunashvili Nino, Karelishvili Natalia, Etsadashvili Nana
Department of Medical Faculty, Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia.
Department of Medical Faculty, Physician Assistant Program, University of Toronto, Toronto, Canada.
Gynecol Endocrinol. 2021 Sep;37(9):819-822. doi: 10.1080/09513590.2021.1943344. Epub 2021 Jun 29.
we evaluated clinical features, the hormonal status, and ovarian morphological characteristics using ultrasound (US) in adolescents with polycystic ovary syndrome (PCOS) and an 'increased risk' of PCOS, and compared the data to age-matched controls.
the prospective study involved 154 adolescents (≥2 and <8 years post menarche): Group I-adolescents with PCOS ( = 60), Group II- adolescents with an 'increased risk' of PCOS ( = 48), and Group III- control group ( = 46). PCOS patients met all 3 diagnostic criteria of the Rotterdam consensus (2003), an 'increased risk' of PCOS was accepted as 'menstrual irregularities and clinical and/or biochemical hyperandrogenism'.
In adolescents with PCOS and 'increased risk' of PCOS, AMH and SHBG did not differ significantly. In Group I and Group II, the average AMH level was significantly higher, while SHBG was significantly lower than in the controls ( < .001). Androgen levels and mFG in Group I and Group II did not differ significantly, but were significantly higher than in controls ( < .001). In Group I, index of insulin resistance and the number of antral follicles (AFC) were significantly higher than in the comparison groups ( < .05). There was no significant difference in ovarian volume between comparison groups ( < .001).
A combination of AMH, SHBG, clinical and biochemical hyperandrogenism and menstrual irregularities may be considered as diagnostic markers of PCOS in adolescents and for the identification of a 'risk group' for developing PCOS. Ultrasound estimation of AFC are a more specific marker of ovarian morphology in adolescents with PCOS, rather than ovary volume.
我们运用超声(US)评估了多囊卵巢综合征(PCOS)青少年患者以及PCOS“高风险”青少年患者的临床特征、激素状态和卵巢形态特征,并将数据与年龄匹配的对照组进行比较。
这项前瞻性研究纳入了154名青少年(初潮后≥2年且<8年):第一组为PCOS青少年患者(n = 60),第二组为PCOS“高风险”青少年患者(n = 48),第三组为对照组(n = 46)。PCOS患者符合鹿特丹共识(2003年)的所有3项诊断标准,PCOS“高风险”定义为“月经不规律以及临床和/或生化高雄激素血症”。
PCOS青少年患者和PCOS“高风险”青少年患者的抗苗勒管激素(AMH)和性激素结合球蛋白(SHBG)无显著差异。在第一组和第二组中,平均AMH水平显著更高,而SHBG显著低于对照组(P <.001)。第一组和第二组的雄激素水平和改良Ferriman-Gallwey(mFG)评分无显著差异,但显著高于对照组(P <.001)。在第一组中,胰岛素抵抗指数和窦卵泡数(AFC)显著高于比较组(P <.05)。比较组之间的卵巢体积无显著差异(P <.001)。
AMH、SHBG、临床和生化高雄激素血症以及月经不规律的综合指标可被视为青少年PCOS的诊断标志物以及识别PCOS“风险组”的指标。超声评估AFC是PCOS青少年患者卵巢形态的更特异标志物,而非卵巢体积。